Evidence map›Paper›PMID 35541867›Full record

ArticleRSC advances2018

Maleimide end-functionalized poly(2-oxazoline)s by the functional initiator route: synthesis and (bio)conjugation.

Gabriela Gil Alvaradejo, Mathias Glassner, Richard Hoogenboom, Guillaume Delaittre

Abstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Determination ofRoyal Society open science · 2024
    Article
  2. BRET-based biosensors for SARS-CoV-2 oligonucleotide detection.Frontiers in bioengineering and biotechnology · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gabriela Gil AlvaradejoInstitute of Toxicology and Genetics (ITG), Karlsruhe Institute of Technology (KIT) Hermann-von-Helmholtz-Platz 176344 Eggenstein-Leopoldshafen Germany guillaume.delaittre@kit.edu.
Mathias GlassnerSupramolecular Chemistry Group, Department of Organic and Macromolecular Chemistry, Ghent University Krijgslaan 281 S4 9000 Ghent Belgium.
Richard HoogenboomSupramolecular Chemistry Group, Department of Organic and Macromolecular Chemistry, Ghent University Krijgslaan 281 S4 9000 Ghent Belgium.ORCID https://orcid.org/0000-0001-7398-2058
Guillaume DelaittreInstitute of Toxicology and Genetics (ITG), Karlsruhe Institute of Technology (KIT) Hermann-von-Helmholtz-Platz 176344 Eggenstein-Leopoldshafen Germany guillaume.delaittre@kit.edu.ORCID https://orcid.org/0000-0002-1741-1506

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of poly(2-ethyl-2-oxazoline)s with a maleimide group at the α chain end was carried out from new sulfonate ester initiators bearing a furan-protected maleimide group. The conditions of the polymerization were optimized for 50 °C using conventional heating (in contrast to microwave irradiation) to counteract the thermal lability of the cycloadduct introduced to protect the maleimide double bond. At this temperature, a tosylate variant was found to be unable to initiate the polymerization after several days. The controlled polymerization of 2-ethyl-2-oxazoline with a nosylate derivative was, however, successful as shown by kinetic experiments monitored by gas chromatography (GC) and size-exclusion chromatography (SEC). Poly(2-ethyl-oxazoline)s of various molar masses (4500 <

Identifiers

PMID35541867
PMCPMC9078655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.